Literature DB >> 6862627

Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.

J D Ernst, J M Decazes, M A Sande.   

Abstract

Two groups of rabbits with experimental meningitis induced by direct intracisternal inoculation of Streptococcus pneumoniae cells were studied. One group was rendered profoundly leukopenic by nitrogen mustard, and the other had normal leukocyte counts. The two groups had comparable bacterial growth rates (mean generation time, 60 versus 67 min) and ultimate bacterial populations in the cerebrospinal fluid (CSF) (mean log10 CFU, 9.1 versus 8.7); therefore leukocytes did not effectively slow or limit the growth of pneumococci in the CSF in vivo. Increased CSF protein, decreased CSF glucose, and increased CSF lactate levels were similar in both groups, suggesting that leukocytes are not essential for these changes to occur. Quantitative blood cultures revealed identical levels of pneumococcal bacteremia until 13 to 14 h after the initiation of infection, when the leukopenic rabbits showed a larger number of pneumococci in the blood, ultimately exceeding the number reached in nonleukopenic rabbits by 100-fold. Leukocytes therefore limit the extent of pneumococcal bacteremia after infection of the CSF despite their lack of effect on the course or the CSF manifestations of experimental meningitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862627      PMCID: PMC264774          DOI: 10.1128/iai.41.1.275-279.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Experimental pneumococcal meningitis. II. Characterization and quantitation of the inflammatory process.

Authors:  C K McAllister; J M O'Donoghue; H N Beaty
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

2.  Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.

Authors:  M S Simberkoff; N H Moldover; J Rahal
Journal:  J Lab Clin Med       Date:  1980-03

3.  Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone.

Authors:  W M Scheld; R G Dacey; H R Winn; J E Welsh; J A Jane; M A Sande
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

4.  Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation.

Authors:  C M Nolan; C K McAllister; E Walters; H N Beaty
Journal:  J Lab Clin Med       Date:  1978-06

5.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Authors:  W M Scheld; M A Sande
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

6.  A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

Authors:  E J Brown; S W Hosea; C H Hammer; C G Burch; M M Frank
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

7.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis.

Authors:  A Zwahlen; U E Nydegger; P Vaudaux; P H Lambert; F A Waldvogel
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

9.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo.

Authors:  M A Sande; O M Korzeniowski; G M Allegro; R O Brennan; O Zak; W M Scheld
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
  10 in total
  35 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 2.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

3.  Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis.

Authors:  T O'Reilly; C Ostergaard; J Vaxelaire; O Zak
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 4.  Current concepts in bacterial meningitis.

Authors:  S M Hahn
Journal:  West J Med       Date:  1989-08

5.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.

Authors:  M G Täuber; S Kunz; O Zak; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

6.  Cellular basis of host defence in pyelonephritis. II. Acute infection.

Authors:  T E Miller; G Findon; S Cawley; I Clarke
Journal:  Br J Exp Pathol       Date:  1986-04

7.  Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.

Authors:  A Wellmer; J Gerber; J Ragheb; G Zysk; T Kunst; A Smirnov; W Brück; R Nau
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat.

Authors:  A J Lesse; E R Moxon; A Zwahlen; W M Scheld
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

9.  Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis.

Authors:  X Sáez-Llorens; O Ramilo; M M Mustafa; J Mertsola; C de Alba; E Hansen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.

Authors:  Christian T Brandt; Jens D Lundgren; Søren Peter Lund; Niels Frimodt-Møller; Thomas Christensen; Thomas Benfield; Frank Espersen; David M Hougaard; Christian Østergaard
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.